- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
ZN.2: 5 residues within 4Å:- Chain A: C.479, C.499, C.506, C.572
- Ligands: ZN.3
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.479, A:C.499, A:C.506, A:C.572
ZN.3: 6 residues within 4Å:- Chain A: C.477, Q.478, C.479, C.482, C.498
- Ligands: ZN.2
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.477, A:C.479, A:C.482, A:C.498
ZN.13: 5 residues within 4Å:- Chain B: C.479, C.499, C.506, C.572
- Ligands: ZN.14
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.479, B:C.499, B:C.506, B:C.572
ZN.14: 6 residues within 4Å:- Chain B: C.477, Q.478, C.479, C.482, C.498
- Ligands: ZN.13
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.477, B:C.479, B:C.482, B:C.498
ZN.23: 5 residues within 4Å:- Chain C: C.479, C.499, C.506, C.572
- Ligands: ZN.24
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.479, C:C.499, C:C.506, C:C.572
ZN.24: 6 residues within 4Å:- Chain C: C.477, Q.478, C.479, C.482, C.498
- Ligands: ZN.23
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.477, C:C.479, C:C.482, C:C.498
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 4 residues within 4Å:- Chain A: R.183, S.184, E.186, N.187
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.187
NAG.5: 3 residues within 4Å:- Chain A: N.241, T.243, E.244
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.244, A:E.244
NAG.15: 4 residues within 4Å:- Chain B: R.183, S.184, E.186, N.187
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.187
NAG.16: 3 residues within 4Å:- Chain B: N.241, T.243, E.244
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.244, B:E.244
NAG.25: 4 residues within 4Å:- Chain C: R.183, S.184, E.186, N.187
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.187
NAG.26: 3 residues within 4Å:- Chain C: N.241, T.243, E.244
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:E.244, C:E.244
- 15 x PLM: PALMITIC ACID(Covalent)
PLM.6: 10 residues within 4Å:- Chain A: L.353, L.354, T.357, Y.358, S.360, F.362, C.363, V.367
- Ligands: PLM.9, PLM.10
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.353, A:L.354, A:Y.358, A:F.362, A:V.367
- Hydrogen bonds: A:S.360
PLM.7: 3 residues within 4Å:- Chain A: V.367, C.371
- Ligands: PLM.9
No protein-ligand interaction detected (PLIP)PLM.8: 2 residues within 4Å:- Chain A: C.373
- Ligands: PLM.9
No protein-ligand interaction detected (PLIP)PLM.9: 6 residues within 4Å:- Chain A: Y.358, V.367, C.374
- Ligands: PLM.6, PLM.7, PLM.8
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.358
PLM.10: 8 residues within 4Å:- Chain A: N.25, V.29, C.350, L.354, Y.358, C.377, N.380
- Ligands: PLM.6
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.29, A:L.354
- Hydrogen bonds: A:N.380
PLM.17: 10 residues within 4Å:- Chain B: L.353, L.354, T.357, Y.358, S.360, F.362, C.363, V.367
- Ligands: PLM.20, PLM.21
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.353, B:L.354, B:Y.358, B:F.362, B:V.367
- Hydrogen bonds: B:S.360
PLM.18: 3 residues within 4Å:- Chain B: V.367, C.371
- Ligands: PLM.20
No protein-ligand interaction detected (PLIP)PLM.19: 2 residues within 4Å:- Chain B: C.373
- Ligands: PLM.20
No protein-ligand interaction detected (PLIP)PLM.20: 6 residues within 4Å:- Chain B: Y.358, V.367, C.374
- Ligands: PLM.17, PLM.18, PLM.19
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.358
PLM.21: 8 residues within 4Å:- Chain B: N.25, V.29, C.350, L.354, Y.358, C.377, N.380
- Ligands: PLM.17
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:V.29, B:L.354
- Hydrogen bonds: B:N.380
PLM.27: 10 residues within 4Å:- Chain C: L.353, L.354, T.357, Y.358, S.360, F.362, C.363, V.367
- Ligands: PLM.30, PLM.31
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.353, C:L.354, C:Y.358, C:F.362, C:V.367
- Hydrogen bonds: C:S.360
PLM.28: 3 residues within 4Å:- Chain C: V.367, C.371
- Ligands: PLM.30
No protein-ligand interaction detected (PLIP)PLM.29: 2 residues within 4Å:- Chain C: C.373
- Ligands: PLM.30
No protein-ligand interaction detected (PLIP)PLM.30: 6 residues within 4Å:- Chain C: Y.358, V.367, C.374
- Ligands: PLM.27, PLM.28, PLM.29
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.358
PLM.31: 8 residues within 4Å:- Chain C: N.25, V.29, C.350, L.354, Y.358, C.377, N.380
- Ligands: PLM.27
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:V.29, C:L.354
- Hydrogen bonds: C:N.380
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oken, A.C. et al., A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor. Nat Commun (2025)


- Release Date
- 2025-09-24
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x PLM: PALMITIC ACID(Covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oken, A.C. et al., A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor. Nat Commun (2025)


- Release Date
- 2025-09-24
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.